Found 47 matching trials
Effect of Boceprevir on HCV-specific T Cell Responses N/A Analysis of HCV-specific T cell responses in patients treated with boceprev...
Show More Location
Unit of Infectious Diseases and Hepatology
Learn More & Join Trial
Evaluation of Hepatic Pharmacokinetics for Grazoprevir (MK-5172) in Participants With Chronic Hepatitis C (MK-5172-022) PHASE1 This study is divided into 2 segments, and proposes to qualify fine needle ...
Show More Location
Multiple Locations
Learn More & Join Trial
Pegylated Interferon (PEG-IFN) Alfa-2b and Low Dose Ribavirin for the Treatment of Chronic Hepatitis C Patients With Genotype 1 High Viral Load and Low Body Weight (Study P05172)(COMPLETED) PHASE4 The objective is to evaluate the efficacy and safety of the combination the...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Efficacy of Boceprevir in Asia Pacific Participants With Chronic Hepatitis C Genotype 1 (P07063) PHASE3 This study will assess the efficacy of boceprevir (BOC) in combination with...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety of MP-424/Peginterferon Alfa-2b/Ribavirin Combination in Treatment-Naïve Patients With Chronic Hepatitis C PHASE3 This study will evaluate the efficacy and safety of MP-424 with Peginterfer...
Show More Location
Toranomon Hospital
Learn More & Join Trial
Effect of Infliximab on the Efficacy of Peg-Intron/Ribavirin in Patients With Hepatitis C (Study P04257AM4)(COMPLETED) PHASE3 This is a Phase IIIB, randomized, prospective, multicenter, single-country,...
Show More Location
Multiple Locations
Learn More & Join Trial
Taribavirin Phase 2 Dose Finding Study for the Treatment of Hepatitis C Virus (HCV) PHASE2 The objective of the study is to select an optimal dose of taribavirin by c...
Show More Location
Cedars-Sinai Medical Center, 8635 W. 3rd Street, Suite 590W
Learn More & Join Trial
A Phase 1 Study of MP-424, Peginterferon Alfa 2b, and Ribavirin in Hepatitis C PHASE1 The purpose of this study is to assess the safety, pharmacokinetics, HCV RN...
Show More Location
Toranomon Hospital
Learn More & Join Trial
Boceprevir/PegIFN α-2b/Riba in HCV+ Gt1 Menopausal Women, Nonresponders to PegIFN/Riba or Treatment-naives (MEN_BOC) PHASE3 The cohort of post-menopausal women represents a group of very-difficult-to...
Show More Location
Gastroenterology Unit
Learn More & Join Trial
Efficacy and Safety of the Combination Vitamin D With Standard of Care in Egyptian Patients With Untreated Chronic Hepatitis C PHASE3 The purpose of this study is to show the superiority of a 4 weeks lead-in p...
Show More Learn More & Join Trial